PRESS RELEASE published on 01/30/2024 at 16:04, 2 years 7 months ago VenoStent Enrolls First Subjects in 200-Subject US Clinical Trial VenoStent enrolls its first patient into a 200-subject, one-to-one randomized controlled trial (RCT) to improve outcomes from arteriovenous fistula creation surgery, as part of its SAVE-FistulaS Clinical Trial in the US. This trial marks a significant milestone in the development of bioabsorbable wraps for hemodialysis patients VenoStent SAVE-FistulaS Clinical Trial Arteriovenous Fistula Bioabsorbable Wrap Hemodialysis Patients
PRESS RELEASE published on 07/31/2023 at 16:04, 3 years 1 month ago VenoStent Completes $16M Series A Financing, Receives IDE Approval from FDA to Begin US Trial
Published on 09/02/2026 at 18:45, 1 hour 29 minutes ago Full Circle Lithium Rebrands as FCL-X Fire & Safety Inc. and Provides Corporate Update
Published on 09/02/2026 at 15:00, 5 hours 14 minutes ago Vox Royalty Enters into Binding Agreement to Acquire the White Dam Gold Royalty in Australia
Published on 09/02/2026 at 14:30, 5 hours 44 minutes ago Solitario Completes Phase-One Drilling at Golden Crest - Reports Initial Drill Results for Ponderosa
Published on 09/02/2026 at 14:00, 6 hours 14 minutes ago Orogen Royalties Acquires Two Gold Projects in Southwest Utah
Published on 09/02/2026 at 14:00, 6 hours 14 minutes ago Datametrex Plans to Focus on AI, Data Centre, and Patent Licensing
Published on 09/02/2026 at 19:50, 23 minutes ago Cotecna Strengthens Food Testing Capabilities in India with Geo-Chem's New Food Safety Laboratory in Navi Mumbai, India
Published on 09/02/2026 at 19:00, 1 hour 14 minutes ago PATRIMOINE ET COMMERCE: INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AMF
Published on 09/02/2026 at 18:48, 1 hour 26 minutes ago Original-Research: Rakovina Therapeutics Inc. (von First Berlin Equity Research GmbH): Add
Published on 09/02/2026 at 18:30, 1 hour 44 minutes ago RÉSULTAT DE L’ASSEMBLÉE GÉNÉRALE ORDINAIRE ET EXTRAORDINAIRE DU 2 SEPTEMBRE 2026
Published on 09/02/2026 at 19:03, 1 hour 10 minutes ago Communiqué au dépôt du projet de note d'information établi par Bourrelier Group
Published on 09/02/2026 at 18:00, 2 hours 14 minutes ago Publication du nombre d’actions composant le capital et du nombre total de droits de vote au 31 août 2026
Published on 09/02/2026 at 18:00, 2 hours 14 minutes ago Outstanding shares and voting rights statement at 31 August 2026
